Fiona Wood

Funding is the biggest issue within the healthcare sector and is the one thing that keeps burns surgeon Fiona Wood awake at night, attendees at a Business News Success & Leadership breakfast heard this morning.

A review of Western Australia’s health sector has found an increased spend in preventive measures and an expansion of telehealth technology would be among several changes needed to ensure a sustainable system.

Avita Medical has tapped investors for $16 million as the company prepares to launch its spray-on burns treatment, which was co-developed by medical entrepreneur Fiona Wood.

ANNIVERSARY SPECIAL: From those who risked their own capital to the corporate cowboys of WA Inc and the ‘hired help’ of today, WA’s corporate story features many powerful personalities. This article is part of a special series to mark Business News' 25-year anniversary.

Kate Lamont and Fiona Wood laid out ambitious plans when they joined other business leaders, including John Rothwell and Tony Joyner, speaking at BN’s 25-year anniversary lunch.

Billions have been invested to ensure WA remains at the forefront of medical innovation and discovery.

Technology is dramatically expanding access to and the effectiveness of healthcare from the cities to WA’s most remote parts.

We share seven of the many stories of WA ingenuity and entrepreneurship to have had an impact during the past five decades.

Business News’s inaugural Food for Thought breakfast brought together some of WA’s best female business minds to discuss issues ranging from inequity to ongoing workplace challenges.

SPECIAL REPORT: Technology could help people live independently at home longer and improve care in residential aged care facilities.

Female researchers and entrepreneurs have powered many of WA’s health care advancements.

UPDATED: Cricket legends Justin Langer and Adam Gilchrist and renowned doctor Fiona Wood helped Euroz Hartleys raise a record amount at its third Commission for a Cause Day.

Synergy chief executive David Fyfe survived the Bali bombings 20 years ago and says the incident has since impacted his role as a leader.

Not for profits are grappling with remuneration for their directors, with one major group scaling back its payments.

The state’s commercial health-related research and technology sector has matured.

The medtech company jointly established by Perth burns surgeon Fiona Wood has achieved a landmark regulatory approval in the US for its spray-on skin technology.

Burns surgeon Fiona Wood has been appointed to the board of John Van Der Wielen-chaired biotechnology company Orthocell as it prepares for international commercialisation.

Medical research could be worth more than $2.1 billion per year to the WA economy by 2045, according to fresh research crunching the industry’s numbers for the first time.

A niche course based on a US university platform has proven a successful incubator for Perth’s fledgling biodesign industry.

Former Western Australian governor Kim Beazley has joined the board of Murdoch-based biotechnology company Orthocell, chaired by John Van Der Wielen.

Biotechnology company Orthocell will raise $3.5 million, with proceeds put towards its international market expansion strategy.

Having led multiple corporate transformation projects, John Van Der Wielen shares his thoughts on what works and what doesn’t.

Perth-based biotechnology firm Orthocell has raised $17 million to take its Remplir nerve regeneration product to the world's biggest healthcare market.

The revolutionary spray-on skin treatment developed in Perth by burns surgeon Fiona Wood is being reintroduced to the Australian market by Avita Medical.

Orthocell has submitted its application for US Food and Drug Administration approval for its Remplir nerve regeneration product, marking another moment in a year full of milestones.

Murdoch-based regenerative medicine company Orthocell has posted its third consecutive quarter of record revenue, as it gears up for a final approval from the US FDA for its Remplir nerve product.

Kim Beazley-backed medtech company Orthocell has flagged an expedited expansion into several jurisdictions after strong early sales of its Remplir nerve repair technology.